Quantcast

Latest AstraZeneca Stories

2014-04-11 23:01:51

Transparency Market Research Report Added "Biosimilar And Follow-On Biologics Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018" to its database. Browse Full Report - http://www.transparencymarketresearch.com/biosimilar-and-follow-on-biologics-market.html. Albany, New York, USA (PRWEB) April 11, 2014 There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new...

2014-04-09 23:02:58

Comprehensive research report “OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017” worked out by GlobalData is now available at MarketPublishers.com. According to the study, by 2017-end, pancreatic cancer sales are projected to rise to USD 1.63 billion in the US and 5EU. London, UK (PRWEB) April 09, 2014 The pancreatic cancer market value in the US and 5EU (the six major markets, or 6MM) in 2012 was USD 529 million. Just over 50% of pancreatic cancer...

2014-04-08 00:22:10

BASEL, Switzerland, April 8, 2014 -- Competition explores global challenges through compelling images -- The Award theme is "Scarcity-Waste" -- Open to professionals and amateurs, with $65,000 in prizes on offer /PRNewswire/ -- Syngenta today announced that the second Syngenta Photography Award is now open for entries. The Award aims to stimulate dialogue and create awareness around significant global challenges through powerful photography. The Syngenta Photography Award...

2014-04-02 08:34:05

NES ZIONA, Israel, April 2, 2014 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd (TASE: BNDX), developer of a universal flu vaccine, announced today that its Board of Directors has approved initiation of the process for listing the Company's shares for trading in the US through American Depository Receipt (ADR). The Company will act to register an ADR Level 1 Over-The-Counter (OTC), which does not include the option for public offerings in the US (without additional registration)....

2014-03-31 04:20:51

CAMBRIDGE, England, March 31, 2014 /PRNewswire/ -- Convergence Pharmaceuticals Holdings Limited ("Convergence"), the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, today announces that it has entered into a research alliance with Evotec, a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology...

2014-03-28 12:26:18

DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/8pl45q/investigation) has announced the addition of the "Investigation Report on China Quetiapine Market, 2009-2018" [http://www.researchandmarkets.com/research/8pl45q/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Schizophrenia is a common mental disorder. As a chronic disease, schizophrenia can...

2014-03-28 12:26:09

DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/lj5htc/investigation) has announced the addition of the "Investigation Report on China's Esomeprazole Market, 2009-2018" [http://www.researchandmarkets.com/research/lj5htc/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Digestive system disease is one of the most frequently occurring diseases....

2014-03-26 04:21:13

LONDON and BOSTON, March 26, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, notes that a company presentation to be given by its Chief Executive Officer, Malcolm Weir, at BioCentury Future Leaders in the Biotech Industry [https://www.biocentury.com/conferences/futureleaders/dates ] on 28 March 2014 will be webcast live. The presentation will take place at 9.30am ET in room 302/303 at the Millennium Broadway...

2014-03-25 08:32:50

BASEL, Switzerland, March 25, 2014 /PRNewswire/ -- Syngenta today announced the successful issue of CHF 750 million in Swiss domestic bonds. This issue comprises a CHF 350 million Swiss domestic bond with maturity date in November 2019, a CHF 250 million Swiss domestic bond with maturity date in November 2024 and a CHF 150 million Swiss domestic bond with maturity date in November 2029. John Ramsay, CFO, said: "We have taken advantage of current favorable...

2014-03-25 08:29:14

WARRINGTON, Pa., March 25, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced new appointments to the Company's management team. William C. Roberts has joined the Company as Vice President, Investor Relations and Corporate Communications. In addition, John A. Tattory has been appointed Senior Vice President and Chief Financial Officer. Both Mr. Roberts...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related